Filing Flows › Zymeworks (ZYME) › Q3 2026
Zymeworks (ZYME) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 9, 2026
Zymeworks (ZYME) reported revenue of $256M for the third quarter 2026 (Q3 2026), +829% from a year earlier and up 56-fold from the quarter before. Operating margin was 69.2%, net earnings $174M (67.7% of revenue).
Zymeworks, Q3 2026: revenue $256M (+829% year over year), operating margin 69.2%, net earnings $174M, operating cash flow −$24.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $256M | 56× | +829% |
| Operating profit | $178M | — | — |
| Net earnings | $174M | — | — |
| Operating cash flow | −$24.0M | — | — |
What changed
Revenue was $256.5M in Q3 2026, up 829% year over year and up 5487% from the previous quarter. License and milestone revenue was the largest line at 97% of revenue. License and milestone revenue added $224.8M year over year (up 890%), 98% of the total change.
Operating profit was $177.6M, a 69.2% margin (up 149.3 points year over year). Total costs grew 59% against revenue growth of 829%. The fastest-growing cost line was SG&A (+202%). Net earnings were $173.7M. The effective tax rate was -0.3%.
Operating cash flow was −$24.0M. Non-cash charges added back $1.7M of depreciation and amortization and $23.1M of share-based compensation. Working capital and other items used $222.5M. Capital expenditures of $73K exceeded it, leaving free cash flow of −$24.1M.
Questions
What was Zymeworks' revenue in the third quarter 2026?
Zymeworks (ZYME) reported revenue of $256M for the third quarter 2026 (Q3 2026), +829% from a year earlier and up 56-fold from the quarter before.
Was Zymeworks profitable in the third quarter 2026?
Operating profit was $178M (69.2% of revenue) and net earnings $174M.
Source: Zymeworks 10-Q on SEC EDGAR.